VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $522,467 | -14.1% | 19,415 | -3.9% | 0.01% | 0.0% |
Q2 2023 | $608,183 | -19.7% | 20,199 | -13.7% | 0.01% | 0.0% |
Q1 2023 | $757,175 | +16.6% | 23,406 | +3.3% | 0.01% | +22.2% |
Q4 2022 | $649,112 | +4.5% | 22,649 | -12.0% | 0.01% | 0.0% |
Q3 2022 | $621,000 | +6.5% | 25,743 | +20.8% | 0.01% | 0.0% |
Q2 2022 | $583,000 | -25.0% | 21,303 | +5.1% | 0.01% | -10.0% |
Q1 2022 | $777,000 | -6.0% | 20,278 | -21.4% | 0.01% | -28.6% |
Q4 2021 | $827,000 | -60.3% | 25,802 | -63.5% | 0.01% | -48.1% |
Q3 2021 | $2,083,000 | -13.9% | 70,682 | -0.7% | 0.03% | -12.9% |
Q2 2021 | $2,419,000 | +33.7% | 71,182 | +27.9% | 0.03% | +24.0% |
Q1 2021 | $1,809,000 | -14.1% | 55,652 | -4.8% | 0.02% | -19.4% |
Q4 2020 | $2,106,000 | +16.7% | 58,481 | +27.0% | 0.03% | +3.3% |
Q3 2020 | $1,804,000 | +387.6% | 46,055 | +356.9% | 0.03% | +328.6% |
Q2 2020 | $370,000 | – | 10,080 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |